Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin-8 (SNX8) is a member of the sorting nexin family, characterized by a conserved PX (phox homology) domain that binds to phosphoinositides, facilitating its localization to endosomal and lysosomal membranes[3]. SNX8 plays a critical role in lysosome tubulation and reformation, a process required for restoring lysosomal function and recycling lysosomal components, particularly under conditions where lysosome pools are diminished[1]. It has the ability to induce membrane curvature due to its BAR domain, and interacts with lysosomal proteins such as LAMP1. SNX8’s activity is essential for maintaining protein and organelle homeostasis via its involvement in endosomal and lysosomal pathways. Disruption of SNX8 function results in cellular phenotypes typical of lysosomal storage disorders and SNX8 deficiencies are implicated in neurodegenerative and other human diseases[1][2][3]. Overexpression or upregulation of SNX8 may rescue cellular dysfunctions associated with these pathologies, suggesting emerging therapeutic potential[1].
Promotion of lysosome reformation via induction of tubulation and membrane recycling; Binding of phosphoinositides on lysosome/endosome membranes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin-8 (SNX8).